Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Arch. endocrinol. metab. (Online) ; 67(4): e000613, Mar.-Apr. 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1439232

ABSTRACT

ABSTRACT Objective: The study sought to determine the clinical features of hyperparathyroid-induced hypercalcemic crisis (HIHC) along with treatment options and outcomes. Subjects and methods: This is a retrospective analysis of our historical cohort of patients with primary hyperparathyroidism (PHPT). Patients were divided in groups according to their calcium levels and clinical presentation. HIHC (group 1) was assumed when patients had high calcium levels and needed emergency hospitalization. Group 2 was composed of patients with calcium levels above 16 mg/dL or patients who needed hospitalization for classical PHPT symptoms. Group 3 was composed of clinically stable patients with calcium levels between 14 and 16 mg/dL, who were electively treated. Results: Twenty-nine patients had calcium levels above 14 mg/dL. HIHC group had seven patients, and initial clinical measures had good response in two patients, moderate response in one patient, and poor response in four patients. All poor responders underwent immediate surgery, and one of them died due to HIHC complications. Group 2 had nine patients, and all were successfully treated during hospitalization. Group 3 had 13 patients, and all had a successful elective surgery. Conclusion: HIHC is a life-threatening condition that requires fast clinical intervention. Surgery is the only definitive treatment and should be planned for all patients. Poor response to initial clinical measures should direct treatment toward surgery to avoid disease progression and clinical deterioration.

2.
Int. arch. otorhinolaryngol. (Impr.) ; 24(1): 107-111, Jan.-Mar. 2020. tab, graf
Article in English | LILACS | ID: biblio-1090552

ABSTRACT

Abstract Introduction Obstructive sleep apnea syndrome (OSAS) is a multifactorial disease characterized by episodes of partial or complete collapse during sleep of different regions of the upper airway. Surgery for OSAS evolved with the introduction of different techniques, considering new surgical concept of reconstruction of the upper airway. Objective To retrospectively evaluate the effectiveness of a new approach aimed at reducing pharyngeal collapse by combining two surgical techniques: lateral and expansion pharyngoplasty. Methods We reviewed the medical records of 38 patients with OSAS undergoing lateral/expansion pharyngoplasty from January 2012 to December 2016. The following data were collected: patient age, gender, and pre- and postoperative body mass index (BMI), Epworth sleepiness scale (ESS) scores, snoring visual analogue scale (VAS) scores, and polysomnography (PSG) results. Results The PSG results showed a significant reduction in the apnea/hypopnea index (AHI) from 22.4 ± 27.3 events/h preoperatively to 13.6 ± 17.9 events/h postoperatively (p = 0.009), with postoperative AHI reduction greater than 50% in 63.2% of the patients. There was also a significant reduction in the microarousal index (19.5 ± 22.6 vs 11.0 ± 13.4 events/h; p = 0.001) and in the minimum oxygen saturation (82.6 ± 10.3 vs 86.9 ± 11.1; p = 0.007). Conclusions Lateral-expansion pharyngoplasty represents a new surgical strategy for the treatment of OSAS in patients with palatal collapse by combining two different techniques: lateral and expansion pharyngoplasty. The two techniques, performed as a one-stage procedure, led to improvements in excessive daytime sleepiness, snoring, and PSG respiratory parameters by acting on lateral and retropalatal collapse, produc- ing favorable results with good applicability in otolaryngology clinical practice.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Pharynx/surgery , Otorhinolaryngologic Surgical Procedures/methods , Plastic Surgery Procedures/methods , Sleep Apnea, Obstructive/surgery , Pharyngeal Muscles/surgery , Medical Records , Retrospective Studies , Longitudinal Studies , Treatment Outcome
3.
Arch. Head Neck Surg ; 48(2): e00222019, Apr.-June. 2019.
Article in English | LILACS-Express | LILACS | ID: biblio-1391158

ABSTRACT

Introduction: Primary hyperparathyroidism (PHPT) is a common disease, ranking third among endocrinological disorders. Surgical intervention remains the only curative therapy for hyperparathyroidism patients. Objective: To evaluate whether the values of parathyroid hormone (PTH) collected from the internal jugular veins of patients with primary hyperparathyroidism can assist in the surgical approach. Methods: Prospective study of patients who underwent parathyroid adenoma excision by PHPT, collected right and left internal jugular vein blood sample for analysis of Parathyroid Hormone. Results: Twenty-nine patients underwent surgery. All patients had a decrease in peripheral PTH greater than 50% with a mean of 73.47%. PTH collection from the internal jugular veins was positive regarding the confirmation of parathyroid adenoma laterality in 22 cases (75.86%) and failure in 7 cases (24.14%), (p-value 0.001). Comparing the success rates of the methoxyisobutylisonitrile parathyroid scintigraphy (MIBI) tests, parathyroid ultrasonography (USG) and PTH of internal jugulars in relation to location of adenoma laterality, we observed MIBI as localizer in 89.65% of the cases followed by the Jugular PTH with 75.86% and USG with 44.82%. Conclusion: PTH collection from the internal jugular veins is useful in patients with primary hyperparathyroidism who underwent surgery as a possible method of localizatory exams, indicating adenoma laterality.

4.
Article in English | LILACS | ID: lil-788013

ABSTRACT

Abstract Introduction Obstructive sleep apnea (OSA) is characterized by partial or complete recurrent upper airway obstruction during sleep. OSA brings many adverse consequences, such as hypertension, obesity, diabetes mellitus, cardiac and encephalic alterations, behavioral, among others, resulting in a significant source of public health care by generating a high financial and social impact. The importance of this assessment proves to be useful, because the incidence of patients with comorbidities associated with AOS has been increasing consistently and presents significant influence in natural disease history. Objective The objective of this study is to assess major comorbidities associated with obstructive sleep apnea (OSA) and prevalence in a group of patients diagnosed clinically and polysomnographically with OSA. Methods This is a retrospective study of 100 charts from patients previously diagnosed with OSA in our service between October 2010 and January 2013. Results We evaluated 100 patients with OSA (84 men and 16 women) with a mean age of 50.05 years (range 19-75 years). The prevalence of comorbidities were hypertension (39%), obesity (34%), depression (19%), gastroesophageal reflux disease (GERD) (18%), diabetes mellitus (15%), hypercholesterolemia (10%), asthma (4%), and no comorbidities (33%). Comorbidities occurred in 56.2% patients diagnosed with mild OSA, 67.6% with moderate OSA, and 70% of patients with severe OSA. Conclusion According to the current literature data and the values obtained in our paper, we can correlate through expressive values obesity with OSA and their apnea hypopnea index (AHI) values. However, despite significant prevalence of OSA with other comorbidities, our study could not render expressive significance values able to justify their correlations.


Subject(s)
Humans , Male , Female , Adult , Comorbidity , Polysomnography , Sleep Apnea Syndromes/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL